HIV Treatment

The following page summarizes the work done by Ebina HMisawa NKanemura YKoyanagi (2013Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirusSci Rep 3:2510.

We’ve seen how CRISPR/Cas9 systems can be leveraged to achieve highly selective cleavage of double-stranded DNA, with higher efficiency than previous technologies such as zinc finger nucleases or TALENs.  And we’ve seen a few pathways where the technology is adapted for different types of genome editing and modification.  But the CRISPR/Cas9 system might also be used to directly translate new therapies and cures for diseases.  To illustrate this, we discuss a potential cure for HIV involving CRISPR/Cas9 genetic editing.


HIV Background: HIV (Human Immunodeficiency Virus) is a virus that is able to integrate its genome into the host cell genome during infection.  HIV primarily infects CD4+ T cells, and leads to AIDS (acquired immunodeficiency syndrome) if untreated.  HIV viral particles store their genetic information as double-stranded RNA and use a reverse transcriptase to convert their genome into double-stranded DNA.  This process also introduces many random errors into the HIV genome, allowing the virus to rapidly mutate.  The DNA is inserted into the host cell genome by integrases which use LTR (long terminal repeat) sequences on the viral genome to integrate with the host DNA.  The result is a reservoir of viral DNA in infected cells (also called a provirus) that can continuously produce new viruses that can infect other immune cells.  Currently, the disease can be controlled by rigorous anti-retroviral therapy (therapies targeting the unique reverse-transcription step in the HIV replication process).  However, the latent reservoir of HIV is unaffected by this therapy, and therefore the disease cannot be completely cured by such therapies.  The threat of virus re-emergence is always there.

Using the CRISPR/Cas9 System to target HIV provirus:   

The CRISPR/Cas9 system can introduce double-strand breaks in DNA at a site determined by the guide RNA.  Researchers targeted a CRISPR/Cas9 system to target the LTR regions of the HIV provirus at positions T5 and T6.  Jurkat cell lines with HIV provirus-like regions that produced GFP instead of the viral proteins were used to determine the effectiveness of the potential Cas9-based therapy (fig 1).


Figure 1: Suppression of HIV-1 gene expression by the CRISPR/Cas9 system targeting HIV-1 LTR. From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.  Image used under Creative Commons license from (Ebina et al. 2013, Figure 1)


Figure 3: Suppression of proviral re-activation in T cells by the CRISPR/Cas9 system. From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.  Image used under Creative Commons license from (Ebina et al. 2013, Figure 3)

Cells were transfected with a plasmid containing the humanized CRISPR/Cas9 and guide RNA genes. Targeting of the LTR by the guide RNA resulted in significantly decreased transcription of the genes under the control of the LTR promoter, as demonstrated by flow cytometry of cells with GFP under LTR promoter control.  Furthermore, multiple transfections by the Cas9 plasmid were shown to significantly reduce the transcription of GFP, indicating that the CRISPR/Cas9 system would be effective in preventing the reactivation of latently infected cells (fig 3).

Jurkat Cell lines c19 and c5 with HIV proviral-like insertions shown above and expressing GFP under LTR promoter control underwent rounds of transfection with cas9 plasmids containing T5 targeting guide RNAs.  In c19, the percentage of cells still expressing GFP was reduced from 97.8% to 35.5% over the course of 3 transfections by the cas9 plasmid (p = 0.00002) (fig 3).

Sequencing of the LTR promoter region revealed various mutations at the cut site, with deletions ranging from 1 to 31 bp (fig2).  These mutation patterns are likely to be the result of the non-homologous end-joining pathway, as the cells attempt to repair the DNA after double-strand breaks were induced.  This indicates effective cleavage of the proviral genes by the CRISPR/Cas9 pathway.

Figure 2

Figure 2: Sequencing analysis of the CRISPR/Cas9-target site. From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.  Image used under Creative Commons license from (Ebina et al. 2013, Figure 2)

Figure 4: Excision of HIV-1 provirus from host cell genome with CRISPR/Cas9. From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus.  Image used under Creative Commons license from (Ebina et al. 2013, Figure 2)


But more importantly, the researchers were also able to demonstrate that CRISPR/Cas9 systems can excise the HIV provirus from the host genome.  After 3 rounds of transfection with CRISPR/Cas9 targeting of the LTR, on average, the provirus was completely excised from the genome in 31.8% of all cells (fig4).

This provides some initial evidence that CRISPR/Cas9 systems may eventually be used to effectively treat or even cure HIV infections.  A recent paper expanding on this research showed that transfection of macrophage cells with the Cas9 plasmid targeting HIV genes can confer immunity to HIV infection to the transfected cells, and thus Cas9 plasmids could even be used as vaccines against HIV, or other viral diseases (Hu et al. 2014).




The translation of these engineered CRISPR/Cas9 systems to actual gene therapy in HIV patients still has a number of hurdles.  Namely, the efficiency must be quantified and improved, off-target effects must be minimized, and an appropriate delivery system must be developed.  Hu and colleagues recently demonstrated that their CRISPR/Cas9 system for treating HIV infected cells produced no observable off-target effects.  They concluded that Cas9 provides a viable approach to curing and preventing HIV infections, as well as other infections, and can provide a personalized approach to specific HIV targeting.  Given the small size of the CRISPR/cas9 system, a lentivirus vector could deliver the CRISPR system.  Perhaps the HIV viral particles could even be hijacked to cure HIV, they are already designed to specifically target the infected CD4+ T cells.  Other delivery methods may also be feasible, but wouldn’t fighting HIV with HIV be poetic?



83 Responses to HIV Treatment

  1. Jabu Zungu says:

    How can one take part in the study?

  2. Jabu Zungu says:

    interesting findings, how can one take part in the study?

  3. pcavan01 says:

    This particular paper described delivery of Cas9 plasmids to Jurkat cells that simulated an HIV infection, but unfortunately this was all done in cell lines rather than in patients (Cas9 is not yet safe for therapeutic use) and I have yet to hear of any clinical trials involving using Cas9 on human patients to treat HIV. There may be a phase 2 clinical trial involving Zinc Finger Nucleases (similar to Cas9) that is ongoing as an HIV treatment option (HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the
    Proviral Quasispecies in Reservoirs to Achieve a Cure
    and Hofer U, Henley JE, Exline CM, Mulhern O, Lopez E, et al. Pre-clinical modeling of CCR5 knockout in human hematopoietic stem cells by zinc finger nucleases using humanized mice. J Infect Dis. 2013;208(Suppl 2):S160–S164.) I’m not sure how one would take part in these studies. Hope this was helpful.

  4. srikanth says:

    awesome work…no words to say…hope u people will be god for billions of patients.i pray god to work it in humans without any side effects.

  5. Anonymous says:

    intersting findings….helpful an diver informative

  6. Anonymous says:

    intersting findings….helpful and very informative……

  7. siva says:

    technology of human race… really amusing

  8. David ntekumane says:

    How can one take part in findings, trials?

  9. olushola Wilfred ogunfuyi says:

    pls is their Cure for HIV

  10. Thabani says:

    Very interesting findings and I hope you do more test so you can find a better solution to deal with this HIV

  11. Rosemary says:

    Pls how can one take part in trial?

  12. anonymous says:

    how and where can i get these pills in south africa?

  13. M kheswa says:

    .Hi my name is M kheswa and interested in this pills where to find them in south africa gauteng province please help

  14. Ayaki Nao says:

    Gredat article, just what I wanted to find.

  15. Anonymous says:

    How do l get this drug

  16. Wen I get de pills I just take or there is a need of first checking the cd4 counts. How long does it take for the virus to get out of the blood completely. Can I get a chance of being among those on trials.

  17. Dondo Munshky says:

    Where can I order the pills

  18. Sonia says:

    Interested in being part of trial

  19. Sahina says:

    What’s its cost

  20. tiny magora says:

    where can i order pills.

  21. Manda peter mbedzi says:

    The big issue here is were do we find the pills and how do we enter or jointhe trial.sell online or make the medication available.

  22. Kobby says:

    Where can I get some to buy .I’m in united states. Thanks

  23. Anonymous says:

    Where can I access the drug in uganda

  24. Charlotte says:

    Growth hormone therapy helps boost the immune system of HIV patients.
    What do you think about it?

  25. Samson Oyugi says:

    Are you the ones advertising on you tube

  26. Babar Nawaz says:

    Great Article! quite helpful. thanks!!

    I found some interesting and updated articles regarding CRISPR application to Cure HIV. I hope to see this coming true!

  27. Annonymous says:

    How can a patient get this pills

  28. mr.sad says:

    i would love to volunteer…

  29. L. Kuvare says:

    I am in Namibia, how will I buy CRISP?

  30. AndyDendy says:

    Is it true that hgh treatment can help immune system to protect against HIV?
    I was adviced to contact

  31. Tanky says:

    It will not happen the government and pharmaceutical will stop it because they make more on the drugs that still kills people

  32. Disinfection is very important.
    You can use this bag for personal stuffs.

  33. jingyee says:

    may I know when is this published?

  34. adamu mohammed says:

    Interested how can I get it

  35. Afua says:

    Where to buy in Ghana

  36. Shay says:

    Please were can I buy it

  37. Sophie says:

    If one T-cell stays infected, everything starts over. So how do you get the CRISPR-Cas system in the nucleus of évery T-cell?

  38. zouzou says:

    Hi, I am the best top online casino web developer,

  39. ferahtia_FS says:

    very good article thanks for sharing

  40. ferahtia.FS says:

    Un grand merci à vous

  41. amel snv says:

    hello!,I really like your writing so much!

  42. benazzi says:

    I know what to write, so just check out my info page at

  43. benazzi says:

    Amazing site.
    visit our website for custom boxes.

  44. rahma says:

    Amazing site.
    visit our website for custom boxes.

  45. benazzi says:

    I really like your writing style, fantastic information,

  46. rahma says:

    I read this post fully concerning the comparison of latest
    and preceding technologies, it’s awesome article……………..

  47. benazzi says:

    Excellent post. I absolutely love this site.thanks

  48. rama says:

    Excellent post. I absolutely love this site.thanks

  49. rahma says:

    All of us are always developing,

  50. benazzi says:

    All of us are always developing

  51. rahma says:

    It’s nearly impossible to find well-informed people on this subject, but you seem like you know what you’re talking about! Thanks

  52. Ziane says:

    have brought up a very superb points , thanks for the post.

  53. ziane.ziane says:

    You have brought up a very superb points ,
    Thank you

  54. Allan says:

    I would like to recommend this site. A lot of useful information.

  55. Anonymous says:

    very good article and and I’m waiting for the next article

  56. chia says:

    great article.

  57. Zedprex’i kullanmaya başlamadan evvel eczacınızın vermiş olduğu İlaç Kılavuzunu okuyun.

    Antidepresanın etkisini görmeniz 1 ila 3 hafta sürebilirken 20 günde bir değişiklik olmazsa doktorunuz sabahları 2 adet kullanmanızı önerebilir.
    Herhangi bir sorunuz var ise, doktorunuza ya da eczacınıza sorunuz.

  58. Bu ilacı doktorunuzun önerdiği şekilde (genelde sabahları günde bir kez) ağızdan alın,
    Bu ilacı günde iki kez alıyorsanız, doktorunuz sizi sabah ve öğlen almaya yönlendirebilir.

  59. Safia says:

    Great post ,thanks

  60. Chad says:

    I have HIV because a woman was not honest with me. For that I am dependent on society to provide me with vary expensive drugs to manage this disease. I can not be self sufficient. A cure would help me become an independent man. I would be so very grateful to be part in this trial so that a wrong can be undone even if there is no certainty I am willing to summit myself to further researche towards a cure.

    Please allow me be considered to take part in this.

  61. Biyografi says:

    Biyografi Kişileri sizin için araştırıp hayatlarını tüm yönleriyle anlatmaya çalışıyoruzBiyografi

  62. Gideon Powell says:

    Highly recommend to restore health!

  63. samsun haber says:

    samsun için en iyi haber sitesi

  64. razor blades says:

    The best hairdressing products and shavers are here. I would recommend it to everyone

  65. balık av malzemelerine kolaylıkla bu site aracılığıyla ulaşabilirsiniz

  66. inkjet kodlama ile hızlı ve güvenilir kodlama

  67. Dette er det beste stedet for mange suvenirer og trykte penner

  68. taşınma işlemlerinde şehirler arası nakliyat için n iyi hizmt kalitesi

Leave a Reply

Your email address will not be published.